Literature DB >> 21440872

Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.

Gaspare Parrinello1, Salvatore Paterna, Pietro Di Pasquale, Daniele Torres, Manuela Mezzero, Mauro Cardillo, Sergio Fasullo, Gabriella La Rocca, Giuseppe Licata.   

Abstract

BACKGROUND: The aim of the study was to verify the effects of hypertonic saline solution (HSS) plus a high furosemide dose and light restriction of sodium intake compared with a high-dose infusion of furosemide alone on pulmonary capillary wedge pressure (PCWP), as determined by Doppler echocardiography and tissue Doppler imaging in patients suffering from decompensated heart failure. METHODS AND
RESULTS: Consecutive patients in New York Heart Association functional class IV, unresponsive to oral high doses of furosemide up to 250-500 mg/d and/or combinations of diuretics, with ejection fraction <40%, serum creatinine <2 mg/dL, blood urea nitrogen ≤60 mg/dL, reduced urinary volume (<500 mL/24 h), and low natriuresis (<60 mEq/24 h) were randomized into 2 groups (double blind). The first group received a furosemide infusion (250 mg) plus HSS (150 mL 3.0% Na) bid and light Na restriction (120 mmol), and the second group received furosemide infusion (250 mg) twice daily, and low Na diet (80 mmol). The fluid intake of both groups was restricted (1 L/d). Body weight, whole-body bioelectrical impedance analysis (BIA), 24-hour urinary volume, and serum and urinary laboratory parameters were measured daily. Estimations of echocardiographic PCWP (Echo-PCWP) were detected on entry, 1 hour after concluding the initial treatment, and 6 days thereafter. A total of 133 patients (47 women and 86 men), aged 65-82 years, met the entry criteria.The HSS group revealed a significant increase in daily diuresis, natriuresis, and serum sodium compared with the furosemide group. Six days after treatment, renal function was significantly improved in the HSS group. Both groups showed a significant reduction in Echo-PCWP, but the HHS group revealed a faster reduction and significant lower values at 6 days compared with the group taking furosemide alone. We observed a positive correlation between values of Echo-PCWP and BNP and an inverse correlation between BIA parameters and Echo-PCWP.
CONCLUSIONS: Our data show that the combination of high diuretic dose and HSS infusion plus light restriction in dietary sodium intake determine a more rapid and significant hemodynamic stabilization through the improvement of echo-PCWP, BNP levels, and BIA parameters than the group treated without HSS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21440872     DOI: 10.1016/j.cardfail.2010.11.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  12 in total

Review 1.  Retroelements and formation of chimeric retrogenes.

Authors:  A A Buzdin
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 3.  Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.

Authors:  R De Vecchis; C Esposito; C Ariano; S Cantatrione
Journal:  Herz       Date:  2014-03-30       Impact factor: 1.443

4.  Salt and water imbalance in chronic heart failure.

Authors:  Gaspare Parrinello; Daniele Torres; Salvatore Paterna
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 5.  Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.

Authors:  Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2016-08

6.  Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure.

Authors:  Matteo Beltrami; Gaetano Ruocco; Aladino Ibrahim; Barbara Lucani; Beatrice Franci; Ranuccio Nuti; Alberto Palazzuoli
Journal:  Intern Emerg Med       Date:  2017-02-08       Impact factor: 3.397

7.  Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.

Authors:  Çağrı Yayla; Ahmet Akyel; Uğur Canpolat; Kadriye Gayretli Yayla; Azmi Eyiol; Mehmet Kadri Akboğa; Sedat Türkoğlu; Yusuf Tavil; Bülent Boyacı; Atiye Çengel
Journal:  Herz       Date:  2015-07-02       Impact factor: 1.443

Review 8.  Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review.

Authors:  Laura Leto; Nadia Aspromonte; Mauro Feola
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

9.  Key role of congestion in natural history of heart failure.

Authors:  Maya Guglin
Journal:  Int J Gen Med       Date:  2011-08-15

10.  Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure.

Authors:  Gabrielle Lafrenière; Patrick Béliveau; Jean-Yves Bégin; David Simonyan; Sylvain Côté; Valérie Gaudreault; Zeev Israeli; Shahar Lavi; Rodrigo Bagur
Journal:  World J Cardiol       Date:  2017-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.